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Objective: Aging is characterized by alterations in body composition such as an increase in body fat
and decreases in muscle mass (sarcopenia) and bone density (osteopenia). Leucine supplemen-
tation has been shown to acutely stimulate protein synthesis and to decrease body fat. However,
the long-term effect of consistent leucine supplementation is not well deﬁned. This study inves-
tigated the effect of leucine supplementation during aging.
Methods: Six-month-old rats were divided into three groups: an adult group (n ¼ 10) euthanized at
6 mo of age, a leucine group (n ¼ 16) that received a diet supplemented with 4% leucine for 40 wk,
and a control group (n ¼ 19) that received the control diet for 40 wk. The following parameters
were evaluated: body weight, food intake, chemical carcass composition, indicators of acquired
chronic diseases, and indicators of protein nutritional status.
Results: Body weight and fat were lower in the leucine group after 40 wk of supplementation
compared with the control group but still higher than in the adult group. The lipid and glycemic
proﬁles were equally altered in the control and leucine groups because of aging. In addition,
leucine supplementation did not affect the changes in protein status parameters associated with
aging, such as decreases in body and muscle protein and total serum protein.
Conclusion: The results indicate that leucine supplementation attenuates body fat gain during
aging but does not affect risk indicators of acquired chronic diseases. Furthermore, supplemented
animals did not show signs of a prevention of the decrease in lean mass associated with aging.
 2012 Elsevier Inc. Open access under the Elsevier OA license.Introduction
The process of aging is associated with different physiologic
alterations such as a decrease in the secretion of anabolic
hormones, e.g., growth hormone and insulin-like growth factor-
1 (IGF-1) [1]. Concomitantly, aging is related to changes in body
composition, including a progressive increase in body fat, espe-
cially visceral adipocytes, associated with increased plasma
concentrations of insulin and leptin and increased insulin resis-
tance [2]. In addition, decreases in muscle mass (sarcopenia),964-9, 07/56230-3, and
ation (FAPESP) and grants
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sevier OA license.strength, and functional capacity are observed, and there is an
increased risk of acquired chronic diseases such as obesity and
type 2 diabetes [2]. These changes in body composition are
observed in humans [3] and rodents [2].
Studies involving elderly humans and rats have shown
a decrease in the stimulus of muscle protein synthesis after the
consumption of a normal protein meal [4,5]. The mechanisms
involved in this alteration remain obscure because this synthesis
responds normally when a large amount of amino acids is
continuously infused into aging rats or when administered orally
to elderly humans [4–6]. Katsanos et al. [7] studied young and
elderly humans receiving a mixture of essential amino acids
containing 1.7 g (26%) or 2.8 g (41%) of leucine and found that
only the higher dose of leucine was effective in stimulating
protein synthesis in the elderly subjects, whereas the two doses
stimulated the fractional synthetic rate of muscle protein in
young subjects. Rieu et al. [8] supplemented 22-mo-old rats with
milk proteins that differed in leucine content: b-lactoglobulin
Table 1
Diet composition*
Ingredient AIN-93M diet
(g/kg diet)
Control diet
(g/kg diet)
4% Leucine
diet (g/kg diet)
Cornstarch 620.692 591.392 591.392
Sucrose 100 100 100
Cellulose 50 50 50
Casein 140 140 140
L-Cystine 1.8 1.8 1.8
Soybean oil 40 40 40
Mineral mixture 35 35 35
Vitamin mixture 10 10 10
Choline bitartrate 2.5 2.5 2.5
tert–Butyl hydroquinone 0.008 0.008 0.008
Alanine d 4.89 d
Aspartate d 4.89 d
Glutamate d 4.89 d
Glycine d 4.89 d
Proline d 4.89 d
Serine d 4.89 d
Leucine d d 29.3
* Based on AIN-93M [15].
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herring ﬂour protein (7.3%). The investigators found that meals
containing leucine-rich proteins (b-lactoglobulin and prolacta)
stimulate postprandial muscle protein synthesis in aging rats.
The effects of protein-rich diets on body composition have
been investigated for a long time [6,9]. Studies have shown that
the infusion or acute ingestion of leucine stimulates protein
synthesis and decreases proteolysis, thus favoring a positive
nitrogen balance [4,10,11]. However, few studies have investi-
gated the effect of long-term supplementation with leucine on
body composition. One study found a 47% decrease in body fat
and improvement of protein nutritional status and protein
synthesis capacity in rats receiving a diet containing 1.77%
leucine (50% increase compared with the control diet) after 6 wk
of food restriction [11]. Zhang et al. [12] observed decreases of
25% in body fat, 27% in low-density lipoprotein (LDL), and 53% in
blood cholesterol in mice fed a high-fat diet supplemented with
leucine in drinking water (55 mg/d, 100% increase compared
with the control group). Conversely, Nairizi et al. [13] found that
doubling the daily leucine intake did not improve serum
cholesterol or triacylglycerol concentrations or affect the body
weight gain or adiposity of mice fed a high-fat diet. In addition,
Verhoeven et al. [14] observed no effect on muscle mass,
strength, lipid proﬁle, or glycemia in healthy elderly subjects
supplemented with leucine (7.5 g/d) for 3 mo.
Taken together, the possible beneﬁt of long-term supple-
mentation with leucine in elderly subjects remains unknown.
Therefore, the present study tested the hypothesis that leucine
supplementation during most of the adult life of rats might alter
body composition by decreasing body fat and attenuating the
loss of leanmass, in addition to favoringmetabolic risk indicators
of acquired chronic diseases.
Materials and methods
Animals
Male Sprague-Dawley rats were obtained from the animal house of the
Faculty of Pharmaceutical Sciences, University of S~ao Paulo. The animals were
maintained in boxes with wood shavings (n ¼ 2–3 per cage) under standard
conditions of light (12-h light/dark cycle), temperature (22  2C), and relative
humidity (5510%). During the experiment, the animals had free access towater
and food. All animal procedures were approved by the ethics committee on
animal experiments of the Faculty of Pharmaceutical Sciences, University of S~ao
Paulo and were performed according to the ethical guidelines adopted by the
Brazilian College of Animal Experimentation (protocol 150).
Diet
The diets were prepared at our laboratory according to the recommendations
of the American Institute of Nutrition for adult rodents (AIN-93M) [15]. The diets
were pelleted, and in the diet supplemented with leucine (Ajinomoto, Kawasaki,
Japan) 29.3 g of starch was replaced with an equivalent amount of puriﬁed
L-leucine per kilogram of ration. In the control diet, 29.3 g of starch was replaced
with a mixture of non-essential amino acids (alanine, aspartate, glutamate,
glycine, proline, and serine) to standardize the nitrogen content of the control
diet (Table 1). We chose to add a mixture of non-essential amino acids to the
control diet to minimize possible interferences from supplementation with high
doses of other amino acids. The total nitrogen content of the diets was deter-
mined by the micro-Kjeldahl method [16] and converted into a protein value by
multiplying the dietary nitrogen content by an arbitrary factor (6.25).
Groups and experimental design
The animals started the 4-mo period of adaptation at 2 mo of age. During this
period, the animals were allowed to adapt to the conditions of the experimental
room and to handling. After reaching 6 mo of age, the animals were divided into
three groups: 1) an adult group (n¼ 10) consisting of animals euthanized at 6 mo
of age (baseline condition; the data of these animals serve as a reference of the
metabolic status before the occurrence of alterations resulting from the aging
process), 2) a control group (n ¼ 19) consisting of 6-mo-old animals fed thecontrol diet for 40 wk, and 3) a leucine group (n ¼ 16) consisting of 6-mo-old
animals fed the diet supplemented with 4% leucine for 40 wk. During the course
of the experiment, two rats in the control group and two animals in the leucine
group became ill and were euthanatized before the end of the experiment.
Another rat in the leucine group died in its cage. The causes of these illnesses
were unknown, and the illnesses occurred at different times during the experi-
ment. All the results presented do not include the data of these animals.
Animals in the control and leucine groups were euthanized after 40 wk of
supplementation (16 mo of age). Thus, the effects of leucine supplementation
were evaluated practically throughout the adult life of the animals over a period
of 10 mo. Body weight and food intake were measured weekly throughout the
experiment.
The animals were sacriﬁced 5 h after removal of the diets. Blood samples,
gastrocnemius muscles, and livers were collected and stored at 80C. Adipose
tissues (epididymal and retroperitoneal) were weighed and returned to the
carcass for subsequent analysis of body composition.
Body composition
The body composition of the animals (fat, protein, and humidity) was
determined by chemical analysis of the carcass. The carcass consisted of the
whole body of the animal, except for the blood sample, livers, and gastrocnemius
muscles removed for tissue analysis. Initially, humidity content was determined
by drying the whole carcass in a ventilated oven (approximately 70C) for 7 d.
The carcasses were weighed before being placed in the oven and after being
dried, and the difference between measurements was considered the humidity
content. The whole dry carcass was then chopped and wrapped in gauze and
ﬁlter paper for the determination of body fat by a solvent extraction technique
using a Soxhlet apparatus (SPlabor, Presidente Prudente, SP, Brazil) and ethyl
ether as the solvent. The remaining carcass without humidity and fat was
completely ground (IKA M20 grinder, Labortechnik, Wasserburg, Germany) and
sieved for the removal of hair, which could decrease the homogeneity of the
sample. This process resulted in a homogenous powder that was used to deter-
mine carcass protein by the micro-Kjeldahl method [16]. The quantity of lean
mass was calculated by subtracting the absolute fat value from the total carcass
weight. Fat, protein, and lean mass were calculated as percentages in relation to
carcass weight.
Biochemical analysis
Plasma glucose was assayed by the glucose oxidase method using speciﬁc
commercial kits (Labtest Diagnostica, Lagoa Santa, Brazil). Serum concentrations
of triacylglycerol, cholesterol, and LDL were determined by an enzymatic method
using commercial kits (Labtest Diagnostica). Total plasma protein was analyzed
by colorimetric methods using the Biuret reagent. Muscle protein concentrations
were determined by colorimetric methods using the Folin-Ciocalteau reagent.
The total tissue RNA concentration was determined after extraction of protein
from the samples by ultraviolet absorption at a wavelength of 260 mn in
a spectrophotometer (Shimadzu mini 1240, Kyoto, Japan). Commercial radioim-
munoassay kits were used for the determination of insulin, leptin (Linco, St.
Charles, MO, USA), corticosterone, and testosterone (Diagnostic Systems Labo-
ratories, Inc., Webster, TX, USA). The lower detection limit and the intra-assay
coefﬁcient of variation were, respectively, 0.0359 pmol/mL and 8.9% for insulin,
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pmol/L and 8.6% for testosterone. The IDS Rat/Mouse IGF-1 enzyme-linked
immunosorbent assay kit (Immunodiagnosticsystems, Markham, Ontario,
Canada) was used to assay IGF-1. The homeostasis model assessment (HOMA) of
insulin resistance index was calculated based on the conventional formula:
HOMA ¼ basal glucose (mmol/L)  basal insulin (mU/L)/22.5. The concentration
of amino acids was determined by high-performance liquid chromatographic
analysis of supernatants from trichloroacetic acid extracts of plasma.
Statistical analysis
For statistical analysis of the data, one-way analysis of variance was used for
comparison between groups, and contrasts were obtained by the Newman-Keuls
test. The unpaired two-tailed Student t test was used for the comparison of the
composition of the diets, food intake, and body weight (control versus leucine
group). Partial correlations between data were determined by linear regression
(Pearson). An a value of 0.05 was considered in all analyses. The results are
expressed asmean standard error of themean. Statistical analysiswasperformed
using GraphPad Prism software (GraphPad Software, Inc., San Diego, CA, USA).
Results
Supplementation with leucine attenuated weight gain, body fat
accumulation, and hyperleptinemia associated with aging
Bodyweight gainwas similar in the control and leucine groups
throughout the experimental period. However, in the last month
of supplementation, the leucine group presented a lower body
weight than control animals (Fig. 1A). After 40 wk of the experi-
ment (16 mo of age), the control and leucine groups showed
a greater carcass weight compared with the adult group, but
a signiﬁcantly lower carcass weight was observed in the leucine
group compared with the control group (adult group 560.9 9.9,
control group 806.6  17.7, leucine group 748.6  22.9, P <
0.0001). Food intake was analyzed throughout the experiment
and did not differ between the leucine and control groups
(Fig. 1B). The average daily food intake of the leucine and control
groupswere 22.6 0.8 and 22.4 0.5 g, respectively (P¼ 0.8280).
The aging process resulted in greater accumulation of body
fat (epididymal and retroperitoneal) in the leucine and control
groups compared with the adult group (Fig. 1C–E). However,
long-term supplementation with leucine signiﬁcantly attenu-
ated fat gain as demonstrated by the mass of visceral fat depots
and the percentage of total body fat (Fig. 1C–E).
Leptin concentration is an indicator of the amount of body fat
[17]. As observed for the fat data, the serum leptin concentration
was signiﬁcantly higher in control animals compared with the
adult group (Fig. 1F). No difference between the adult and
leucine-supplemented animals was observed (Fig. 1F). Linear
regression analysis showed that serum leptin concentration
was signiﬁcantly correlated with body fat percentage (P ¼
0.0134, r ¼ 0.388).
Lipid and glycemic proﬁles were not affected by leucine
supplementation
Total cholesterol, triacylglycerol, and LDL concentrations
were higher in control and leucine-supplemented animals
compared with the adult group. No difference in these parame-
ters was observed in control and leucine-fed animals (Fig. 2A–C).
An increase in glucose and insulin levels was observed in the
control and leucine groups compared with the adult group
(Fig. 2D,E). As a consequence, control and leucine-supplemented
animals presented signs of insulin resistance as indicated by the
increased HOMA index compared with the adult group (Fig. 2F).
To determine the role of adiposity in the lipid and glycemic
proﬁles of the animals, the correlation between body fat contentand the levels of total and LDL cholesterol, triacylglycerol,
glucose, and insulin and the HOMA index was analyzed by linear
regression. Adiposity signiﬁcantly inﬂuenced all parameters
indicative of cardiovascular disease, with body fat percentage
showing a positive correlation with concentrations of total
cholesterol (P ¼ 0.0111, r ¼ 0.3976), LDL cholesterol (P ¼ 0.0041,
r ¼ 0.4445), triacylglycerol (P ¼ 0.0100, r ¼ 0.4027), glucose (P <
0.0001, r¼ 0.6353), and insulin (P¼ 0.0085, r¼ 0.4105) and with
the HOMA index (P < 0.0001, r ¼ 0.6234).
Supplementation with leucine did not prevent loss of body
protein and muscle protein during aging
No difference among groups was found in carcass humidity
(adult group 34.8  1.07%, control group 36.54  2.91%, leucine
group 41.19 2.18%, P¼ 0.2321). Decreases in leanmass (Fig. 3A),
total body protein (Fig. 3B), total muscle protein and RNA
concentrations (Fig. 3C–D), and serum total protein concentra-
tion (Fig. 3E) were observed in the control group. There was no
difference in IGF-1 concentration among groups (P > 0.05;
Fig. 3F). Although several studies have shown that acute or short-
term administration of leucine stimulates protein synthesis
and favors a positive nitrogen balance [4,5,10,18], leucine-
supplemented animals presented no signs of improvement in
the indicators of protein nutritional status studied, except for the
lack of a decrease in total RNA concentration in the gastrocne-
mius muscle (Fig. 3D).
No difference in serum testosterone concentration was
observed among the adult, control, and leucine groups (P ¼
0.1429; Fig. 3G). Conversely, serum corticosterone concentration
was signiﬁcantly increased in the control and leucine groups
compared with the adult group (Fig. 3H).
With respect to postprandial (5 h of fasting) blood amino acid
concentrations, increases in blood concentrations of aspartic
acid, serine, threonine, proline, and cystine were observed in
control and leucine-supplemented animals compared with the
adult group. There was no difference in blood amino acid
concentration between the control and leucine groups (Table 2).
Discussion
The present study evaluated the effects of a leucine-rich (4%)
diet in rats during most of their adult life until the onset of old
age (40 wk of supplementation starting at 6 mo of age). The
results conﬁrm the ﬁndings of previous studies showing that
leucine supplementation promotes a decrease in body fat [11,12,
19,20]. However, although signiﬁcant, this decrease attenuated
by only 26% the body fat gain associated with aging. In addition,
leucine supplementation did not affect the metabolic indicators
of acquired chronic diseases, such as total cholesterol, tri-
acylglycerol, and glycemia. Moreover, in contrast to our initial
hypothesis, long-term supplementation with leucine was inef-
fective in attenuating the negative effects of aging on indicators
of protein nutritional status such as muscle RNA, protein
concentration, total body protein, and lean mass.
An important aspect is that leucine supplementation did not
cause any apparent intolerance in the rats. Despite a relatively
high dose of leucine in the diet (4%), which increased leucine
intake approximately four-fold comparedwith the control group,
leucine-fed rats showed a similar food intake throughout the
experiment. In addition, three rats were lost in the leucine group
during the experiment compared with two rats in the control
group. This small difference does not represent a signiﬁcantly
higher mortality rate. Part of leucine metabolism occurs in the
Fig. 1. Long-term leucine supplementation decreased adiposity in aging rats: (A) body weight variation throughout the experiment, (B) food intake, (C) percentage of body
fat, (D) epididymal fat depot, (E) retroperitoneal fat depot, (F) serum concentration of leptin. Values are expressed as mean  SEM. * Signiﬁcantly different (P < 0.05) from the
adult group. # Signiﬁcantly different (P < 0.05) from the control group.
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group into urea. Thus, liver histology was analyzed by hema-
toxylin and eosin staining in liver sections obtained from control
and leucine-fed animals (Vianna et al., personal observations),
and we observed no apparent difference between the two
groups. Taken together, these data indicate that long-term
leucine supplementation has no gross toxic effect on the animals.
Previous studies have suggested that leucine may affect the
energy balance and thus decrease body fat [11,12,21,22]. In this
respect, Zhang et al. [12] observed that, although leucine
supplementation did not affect the metabolism of mice fed
a regular diet, it decreased by 25% the adiposity of animals fed
a high-fat diet. However, Nairizi et al. [13] found no effect of
leucine or branched-chain amino acid (BCAA) supplementation
of drinking water in mice with diet-induced obesity. Although
there is evidence that leucine may affect food intake, as
demonstrated by a decrease in food intake after the central
administration of leucine [23], our data suggest that the decrease
of body weight and fat in the leucine group was probably caused
by changes in energy expenditure because food intake remainedunchanged throughout the experiment. In fact, other studies
reporting an effect of leucine on adiposity did not ﬁnd changes in
food intake, but rather an increase in energy expenditure [11,12].
Knockout mice, which lack the enzyme that catalyzes the ﬁrst
step of BCAA metabolism, mitochondrial branched-chain
aminotransferase, show high plasma concentrations of BCAA
and decreased adipocyte volume and body weight. This pheno-
type is observed despite increased food intake. However, energy
expenditure is also increased, suggesting that changes in energy
expenditure instead of food intake play a prevailing role. Thus, it
is possible that leucine supplementation promoted a discrete
increase of energy expenditure in the animals studied, which
was insufﬁcient to compensate for food intake. However, small
long-term variations in energy expenditure may have favored
the lower fat gain observed in the leucine group.
We also evaluated the plasma concentration of leptin because
other investigators have observed that leucine directly inﬂu-
ences the secretion of leptin by adipocytes [24]. We found
no changes of serum leptin concentration in the leucine
group during aging. Because fat gain was attenuated in the
Fig. 2. Leucine supplementation in aging rats did not improve risk indicators of acquired chronic diseases: serum concentrations of (A) total cholesterol, (B) LDL, (C) tri-
acylglycerol, (D) glucose, and (E) insulin and (F) the HOMA index. Values are expressed as mean  SEM. * Signiﬁcantly different (P < 0.05) from the adult group. HOMA,
homeostasis model assessment; LDL, low-density lipoprotein.
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positively correlated with body fat percentage, the present
results indicate that leptin concentration was more affected by
the difference in adiposity between groups than by the action of
leucine on the synthesis and release of this hormone.
One of themain problems associatedwith increased adiposity
resulting from aging is an increased risk of cardiovascular
diseases [1]. The present results clearly show that aging affected
all cardiovascular risk indicators studied. Although the process of
aging may affect these parameters in different ways, it is likely
that increased adiposity was the main factor. In agreement with
this hypothesis, we found a strong positive correlation between
body fat percentage and levels of total cholesterol, LDL, tri-
acylglycerol, glucose, and insulin and the HOMA index. No
improvement of the lipid or glycemic proﬁle was observed in the
leucine-supplemented group compared with the control group,
indicating that supplementationwith leucine did not prevent the
hyperlipidemia and insulin resistance observed in elderly
animals. Although adiposity was attenuated in the leucine group,
these animals still presented a marked accumulation of body fatcompared with young adult animals (78% and 57% more body fat
in the control and leucine groups, respectively, compared with
the adult group). Thus, the attenuation of fat gain observed with
leucine supplementation was not sufﬁcient to promote an
equivalent decrease in the cardiovascular risk indicators studied.
Leucine is a key amino acid because of its capacity to activate
the intracellular cascade responsible for protein translation [18,
25]. In addition, several studies have demonstrated that the
decreased protein synthesis and increased proteasome-
dependent proteolysis observed in the skeletal muscle of
elderly subjects can be corrected by the administration of leucine
or leucine-rich meals [4,7,8]. In this respect, evidence supports
the possibility that increased ingestion of leucine or of protein
sources rich in leucine favors a positive nitrogen balance in
elderly subjects, preventing the loss of lean mass that leads to
sarcopenia. The present study investigated the effect of
long-term supplementation with leucine on parameters that are
affected in the long term, such as the percentage of body lean
mass, protein, and RNA concentration in skeletal muscle and
indicators of protein nutritional status, e.g., serum total protein
Fig. 3. The aging-dependent decrease in lean mass was not prevented by long-term leucine supplementation: (A) percentage of lean body mass, (B) percentage of body
protein, (C) gastrocnemius protein concentration, (D) gastrocnemius RNA concentration, (E) total serum protein, (F) serum concentration of IGF-1, (G) serum concentration of
testosterone, and (H) serum concentration of corticosterone. Values are expressed as mean  SEM. * Signiﬁcantly different (P < 0.05) from the adult group. IGF-1, insulin-like
growth factor-1.
D. Vianna et al. / Nutrition 28 (2012) 182–189 187and IGF-1. The results showed that continuous consumption of
a diet containing 4% leucine throughout most of the adult life of
rats did not attenuate the loss of protein mass or the worsening
of indicators of protein nutritional status. It is interesting to note
that aging decreased lean mass by 15% in control and leucine-fed
rats compared with adult animals. However, total body protein
was decreased by more than 30% in aging rats. Body humidity
and protein content are the twomajor components of lean mass,
corresponding to approximately 50% and 35% of total lean bodymass, respectively. Because there were no signiﬁcant changes in
carcass humidity among the groups, the decrease of lean mass in
the control and leucine groups can be mainly explained by the
decreased body protein content. In addition, the magnitude of
the decrease in lean mass was lower than that of body protein,
with protein content corresponding to only one-third of lean
body mass.
One major ﬁnding of the present study was that the known
acute effects of leucine on stimulating protein synthesis are not
Table 2
Amino acid concentrations in rat plasma
Amino acids (mmol/L) Adult Control Leucine P
Glutamine 45.0  1.70 50.2  1.30 53.4  3.20 0.0687
Aspartate 4.0  0.20 4.3  0.20* 5.6  0.5* 0.0181
Glutamate 20.9  1.70 21.4  1.70 18.4  1.60 0.4194
Serine 22.2  1.30 28.9  1.40* 33.6  2.1* 0.0002
Glycine 29.0  2.00 32.5  2.4 30.4  3.07 0.6909
Histidine 5.7  0.40 5.0  0.10 6.1  0.30 0.0694
Arginine 11.9  0.80 12.7  1.40 11.8  1.70 0.8514
Threonine 16.3  0.80 23.3  1.10* 25.9  1.70* 0.0001
Alanine 50.7  4.30 58.0  3.00 61.6  3.90 0.1366
Proline 13.5  0.80 15.9  0.80* 15.8  0.30* 0.0295
Tyrosine 8.8  0.60 9.6  0.30 9.6  0.40 0.375
Valine 15.2  0.50 13.2  0.90 12.7  0.60 0.0700
Methionine 7.8  0.30 8.4  0.20 8.1  0.20 0.2660
Cystine 1.2  0.10 1.9  0.10* 1.7  0.20* 0.0111
Isoleucine 9.8  0.30 10.8  0.30 10.3  0.40 0.1489
Leucine 14.0  0.70 11.9  0.60 12.6  0.70 0.1104
Phenylalanine 7.0  0.40 6.7  0.20 7.0  0.20 0.6725
Lysine 27.7  1.30 33.5  1.10 35.2  2.20 0.2022
Taurine 41.5  1.90 42.6  1.80 43.3  2.60 0.8375
Values are expressed as mean  SEM.
* Signiﬁcant difference (P < 0.05) compared with the adult group.
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aggregation. In a recent study in humans, Verhoeven et al. [14]
also showed that supplementation with leucine (7.5 g/d) for
3 mo did not increase muscle mass or strength in healthy elderly
men. According to Balage and Dardevet [26], there is no evidence
that long-term leucine supplementation is efﬁcient in promoting
muscle mass or preventing protein loss during catabolic states.
Although the reason for the discrepancy between the short-term
and long-term effects of leucine is unknown, some studies have
shown that, although leucine is part of the intracellular cascade
activated by insulin, excess amino acids may induce a negative
feedback mechanism that decreases the activation of insulin-
mediated intracellular signaling by inhibiting insulin receptor
substrate 1 through the activation of p70-S6 kinase 1 [12,26–29].
Thus, the intracellular cascade that induces protein translation
might be regulated by a negative feedback loop. Conversely, the
hypothesis of a possible link between the development of
low-grade inﬂammation in elderly subjects and the resistance of
muscle protein synthesis after food intake cannot be ruled out, as
described by others [30,31].
Another possibility is the decreased availability of other
amino acids, especially valine and isoleucine. Studies have sug-
gested that an increased supply of leucine activates enzymatic
complexes responsible for the degradation of BCAA, leading to
the depletion of valine and isoleucine [32–34]. We analyzed
plasma amino acid concentrations after 5 h of fasting and found
no change in the concentrations of valine or isoleucine in the
leucine group compared with the control group. However, after
5 h of fasting, changes in blood amino acid concentrations might
have been blunted because even the concentration of leucine
was unchanged in supplemented animals despite the high level
of dietary leucine. Another hypothesis was that the increased
corticosterone observed in elderly animals produces a state of
leucine resistance during muscle protein synthesis, as demon-
strated by other investigators [19,35]. Further studies are
necessary to clarify why the acute effect of leucine is not trans-
formed into functional gains in protein mass aggregation in
aging animals.
In summary, the present results show that consumption of
a diet rich in leucine attenuates, but does not completely
prevent, the increased adiposity associated with aging. Inaddition, our experimental model showed that a leucine-rich
diet does not prevent the loss of protein mass that occurs
during aging.
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